logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Charles B. Nguyen

city of hope comprehensive cancer center
H指数:9
被引数:360

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing Registry

膀胱和上尿路尿路上皮癌中的生殖系变异：大规模检测登记系统中的患病率及临床背景

European Urology Open Science
IF4.5
2026-02-230
OAAI
Steven M. Monda; Eugene Oh; Patrick J. Lewicki; Samuel D. Kaffenberger; Tobias Else; Zachery R. Reichert; Irene Tsung; Khurshid R. Ghani; Charles B. Nguyen; Rob Humble; Matthew J. Schiewer; Robert Finch; Simpa Salami; Elena M. Stoffel; Todd M. Morgan; Thenappan Chandrasekar; Udit Singhal
Integration of PSMA-Targeted Theranostics into Multidisciplinary Care for Improved Efficiencies and Patient Care

将PSMA靶向诊疗整合到多学科护理中以提高效率和患者护理

JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
IF1.3
2025-12-011
PRE
Kuo, Phillip H.; Poku, Erasmus Kofi; Yamauchi, Dave M.; Cha, Susan H.; Parayno, Maria L.; Chong, Nicole E.; Nguyen, Charles B.; Liu, Sandy T.; Chehrazi-Raffle, Alexander M.; Tripathi, Abhishek; Gerendash, Benjamin S.; Burns, Kathleen D.; Dorff, Tanya B.
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study

在恩沃利单抗之后的尿路上皮癌患者中，萨cituzumab govitecan的疗效：UNITE研究的分析

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
2025-12-010
OAAI
Jindal, Tanya; Jiang, Cindy Y.; Alhalabi, Omar; Davidsohn, Matthew; Freeman, Dory; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Nizam, Amanda; Nguyen, Charles B.; Oh, Eugene; Tsung, Irene; Glover, Michael J.; Khaki, Ali Raza; Taylor, Amy K.; Jaime-Casas, Salvador; Jang, Albert; Lemke, Emily; Pywell, Cameron; Evans, Sean T.; Shin, Denny; Bilen, Mehmet A.; Basu, Arnab; Kilari, Deepak; Tripathi, Abhishek; Brown, Jason; Emamekhoo, Hamid; Davis, Nancy B.; Shah, Sumit; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Alva, Ajjai; Campbell, Matthew T.; Koshkin, Vadim S.
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study

FGFR3突变型晚期尿路上皮癌中，erdafitinib在enfortumab vedotin治疗前或治疗后的疗效：UNITE协作研究的分析

ONCOLOGIST
IF4.2
2025-11-010
PRE
Jiang, Cindy Y.; Hwang, Hyunsoo; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Taylor, Amy K.; Nizam, Amanda; Jindal, Tanya; Glover, Michael J.; Khaki, Ali Raza; Barata, Pedro C.; Nguyen, Charles B.; Oh, Eugene; Davis, Nancy B.; Mabey, Hannah; Hoimes, Christopher J.; Evans, Sean T.; Abuqayas, Bashar; Lemke, Emily; Tsung, Irene; Qiao, Wei; Kilari, Deepak; Zakharia, Yousef; Bilen, Mehmet A.; Milowsky, Matthew, I; Shah, Sumit A.; Gupta, Shilpa; Emamekhoo, Hamid; Bellmunt, Joaquim; Alva, Ajjai S.; Grivas, Petros; Msaouel, Pavlos; Koshkin, Vadim S.; Campbell, Matthew T.; Alhalabi, Omar
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma

抗体药物偶联物联合疗法在晚期尿路上皮癌中的疗效与安全性

Frontiers in Oncology
IF3.3
2025-10-070
OAAI
Salvador Jaime-Casas; Regina Barragan-Carrillo; Miguel Zugman; Koral Shah; Hedyeh Ebrahimi; Benjamin Mercier; Daniela V. Castro; Peter D. Zang; Alexis LeVee; Wesley Yip; Xiaochen Li; Nazli Dizman; Nicholas J. Salgia; Zeynep Zengin; Luis Meza; JoAnn Hsu; Charles B. Nguyen; Alexander Chehrazi-Raffle; Sumanta K. Pal; Abhishek Tripathi
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study

接受恩沃利单抗维多汀治疗的晚期尿路上皮癌患者中的治疗相关不良事件及关联结局：UNITE研究的分析

CANCER MEDICINE
IF3.1
2025-10-020
OAAI
Nizam, Amanda; Nguyen, Charles B.; Li, Jinju; Zabor, Emily C.; Msaouel, Pavlos; Jiang, Cindy Y.; Alhalabi, Omar; Oh, Eugene; Davidsohn, Matthew P.; Epstein, Ilana B.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Jindal, Tanya; Taylor, Amy K.; Glover, Michael J.; Khaki, Ali Raza; Lemke, Emily; Mabey, Hannah; Abuqayas, Bashar; Jang, Albert; Brown, Jason R.; Evans, Sean T.; Pywell, Cameron; Basu, Arnab; Bilen, Mehmet A.; Barata, Pedro C.; Zakharia, Yousef; Milowsky, Matthew I.; Kilari, Deepak; Hoimes, Christopher J.; Shah, Sumit A.; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Campbell, Matthew T.; Alva, Ajjai S.; Koshkin, Vadim S.
VHL and TP53 mutation status are not associated with response or progression-free survival in metastatic renal cell carcinoma treated with VEGF-targeted therapies

VHL和TP53突变状态与接受VEGF靶向治疗的转移性肾细胞癌的治疗反应或无进展生存期无关。

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Castro, Daniela; Zugman, Miguel; Zang, Peter; Shah, Koral; Ebrahimi, Hedyeh; Barragan-Carrillo, Regina; Jaime-Casas, Salvador; Mercier, Benjamin; Dizman, Nazli; Salgia, Nicholas; Hsu, Joann; Nguyen, Charles; Yip, Wesley; Chehrazi-Raffle, Alexander; Tripathi, Abhishek; Pal, Sumanta
Real-World efficacy and safety of belzutifan in sporadic metastatic renal cell carcinoma: a multicenter study from the city of hope enterprise

belzutifan在散发性转移性肾细胞癌中的真实世界有效性与安全性：一项来自City of Hope Enterprise的多中心研究

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Nguyen, Charles; Nguyen, Kim; Ebrahimi, Hedyeh; Zugman, Miguel; Zang, Peter; Pisick, Evan; Kollimuttathuillam, Sudarsan; Mehta, Nilesh; Liu, Sandy; Tripathi, Abhishek; Chehrazi-Raffle, Alexander; Adesunloye, Bamidele; Bryce, Alan; Dorff, Tanya; Pal, Sumanta
Real-World evidence shows no survival advantage with contemporary first-line strategies in papillary renal cell carcinoma: a call for randomized trials

真实世界证据表明，在乳头状肾细胞癌中，当代一线策略并未显示出生存优势：呼吁开展随机试验

ONCOLOGIST
IF4.2
2025-10-010
OA
Zugman, Miguel; Rider, Jennifer R.; Dizman, Nazli; Jaime-Casas, Salvador; Goes, Vitor Abreu; Shah, Koral; Castro, Daniela, V; Mercier, Benjamin; Zang, Peter; Ebrahimi, Hedyeh; Barragan-Carrillo, Regina; Sahu, Diwyanshu; Mandora, Prithviraj Vikramsinh; Hsu, Joann; Yip, Wesley; Nguyen, Charles B.; Chehrazi-Raffle, Alex; Miller, Robert; Powles, Thomas; Choueiri, Toni; Pal, Sumanta K.
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study

恩福妥单抗（Enfortumab Vedotin）在具有不同组织学亚型的晚期尿路上皮癌患者中的疗效：UNITE研究的分析

European Urology
IF25.2
2025-09-140
PRE
Tanya Jindal; Cindy Y. Jiang; Omar Alhalabi; Charles B. Nguyen; Eugene Oh; Irene Tsung; Dimitra Rafailia Bakaloudi; Rafee Talukder; Matthew Davidsohn; Dory Freeman; Ilana Y. Epstein; Chien-Kuang Cornelia Ding; Amanda Nizam; Michael J. Glover; Ali Raza Khaki; Amy K. Taylor; Emily Lemke; Albert Jang; Sean T. Evans; Denny Shin; Cameron Pywell; Arnab Basu; Mehmet A. Bilen; Yousef Zakharia; Pedro Barata; Matthew I. Milowsky; Jason Brown; Deepak Kilari; Hamid Emamekhoo; Christopher J. Hoimes; Sumit Shah; Nancy B. Davis; Shilpa Gupta; Petros Grivas; Joaquim Bellmunt; Ajjai Alva; Matthew T. Campbell; Vadim S. Koshkin
Clinical and Pathological Predictors for Occult Lymph Node Involvement in Patients With Clinical Node-Negative Bladder Cancer Undergoing Radical Cystectomy

临床和病理学预测因子：在接受根治性膀胱切除术的临床淋巴结阴性的膀胱癌患者中 occult 淋巴结受累的预测因子

CLINICAL GENITOURINARY CANCER
IF0
2025-09-010
PRE
Jaime-Casas, Salvador; Zugman, Miguel; Barragan-Carrillo, Regina; Ebrahimi, Hedyeh; Shah, Koral; Yip, Wesley; Hugen, Cory M.; Chan, Kevin G.; Lau, Clayton S.; Yuh, Bertram E.; Mercier, Benjamin; Salgia, Nicholas J.; Castro, Daniela V.; Li, Xiaochen; Hsu, Joann; Nguyen, Charles B.; Chehrazi-Raffle, Alexander; Pal, Sumanta K.; Tripathi, Abhishek
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data

与恩夫妥单抗韦汀疗效相关的基因组生物标志物：对UNITE研究数据的分析

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-12-011
OAAI
Jindal, Tanya; Jiang, Cindy; Alhalabi, Omar; Nizam, Amanda; Nguyen, Charles; Talukder, Rafee; Bakaloudi, Dimitra; Davidsohn, Matthew; Freeman, Dory; Glover, Michael; Khaki, Ali Raza; Evans, Sean; Lemke, Emily; Bose, Rohit; Sim, Woogwang; Pywell, Cameron; Basu, Arnab; Kilari, Deepak; Barata, Pedro C.; Bilen, Mehmet A.; Zakharia, Yousef; Milowsky, Matthew I.; Shah, Sumit A.; Bellmunt, Joaquim; Grivas, Petros; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Hoimes, Christopher; Campbell, Matthew T.; Alva, Ajjai; Koshkin, Vadim S.
Pre-treatment (Tx) risk factors for enfortumab vedotin-induced peripheral neuropathy (EVIPN) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of UNITE

恩沃利单抗 vedotin（Enfortumab vedotin）诱导的外周神经病变（EVIPN）在晚期尿路上皮癌（aUC）患者中的预处理（Tx）危险因素：UNITE 分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Nizam, A.; Zhang, L.; Jiang, C. Y.; Nguyen, C. B.; Bakaloudi, D. R.; Bilen, M. A.; Barata, P. M. Coelho; Zakharia, Y.; Milowsky, M. I.; Kilari, D.; Hoimes, C. J.; Khaki, A. R.; Emamekhoo, H.; Gupta, S.; Grivas, P.; Bellmunt, J.; Alva, A. S.; Campbell, M. T.; Alhalabi, O.; Koshkin, V. S.
Efficacy of enfortumab vedotin (EV) in patients (pts) with (w) advanced urothelial carcinoma (aUC) who have baseline neuropathy (N) and/or diabetes mellitus (DM): A UNITE study analysis

恩诺妥昔单抗（EV）在具有基线神经病变（N）和/或糖尿病（DM）的晚期尿路上皮癌（aUC）患者（pts）中的疗效：一项UNITE研究的分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Jang, A.; Jindal, T.; Jiang, C. Y.; Nguyen, C. B.; Nizam, A.; Alva, A. S.; Grivas, P.; Bellmunt, J.; Hoimes, C. J.; Bilen, M. A.; Emamekhoo, H.; Milowsky, M. I.; Khaki, A. R.; Gupta, S.; Campbell, M. T.; Alhalabi, O.; Chen, Z.; Fu, P.; Koshkin, V. S.; Brown, J. R.
Impact of PTEN alterations on clinical outcomes in patients (pts) with de novo metastatic prostate cancer (mPC)

PTEN基因改变对初诊转移性前列腺癌(mPC)患者临床结局的影响

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Thapa, B.; Henderson, N.; Tagawa, S. T.; Hwang, C.; Sokolova, A. O.; Bilen, M. A.; Barata, P. M. Coelho; Nguyen, C. B.; Tripathi, A.; Ayanambakkam, A.; Graham, L. S.; Zakharia, Y.; Koshkin, V. S.; Heath, E.; Dorff, T. B.; Armstrong, A. J.; Mckay, R. R.; Alva, A. S.; Schweizer, M.; Kilari, D.
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial
CLINICAL CANCER RESEARCH
IF10.2
2024-05-245
PRE
Nguyen, Charles B.; Reimers, Melissa A.; Perera, Chamila; Abida, Wassim; Chou, Jonathan; Feng, Felix Y.; Antonarakis, Emmanuel S.; Mckay, Rana R.; Pachynski, Russell K.; Zhang, Jingsong; Reichert, Zachery R.; Palmbos, Phillip L.; Caram, Megan E. V.; Vaishampayan, Ulka N.; Heath, Elisabeth I.; Hopkins, Alexander C.; Cieslik, Marcin P.; Wu, Yi-Mi; Robinson, Dan R.; Baladandayuthapani, Veerabhadran; Chinnaiyan, Arul M.; Alva, Ajjai S.

研究方向

暂未获取到该数据
A
Ajjai Alva
H 指数:59论文数:458被引数:1.6万
D
Deepak Kilari
H 指数:21论文数:212被引数:1,761
M
Mehmet Asım Bilen
H 指数:49论文数:665被引数:1.1万
M
Matthew T. Campbell
H 指数:33论文数:403被引数:8,254
V
Vadim S. Koshkin
H 指数:29论文数:280被引数:5,202
A
Amanda Nizam
H 指数:12论文数:93被引数:1,003
H
Hamid Emamekhoo
H 指数:25论文数:212被引数:2,582
M
Matthew I. Milowsky
H 指数:66论文数:575被引数:1.8万
J
Joaquim Bellmunt
H 指数:106论文数:1,140被引数:6.6万
C
Christopher Hoimes
H 指数:41论文数:361被引数:7,851